Accounts Payable

9 Months Ended

Sep. 30, 2014

Accounts Payable Disclosure [Abstract]

Accounts Payable

4. Accounts Payable

As of September 30, 2014, Current Liabilities included accounts payable of $88,514 comprised primarily of approximate amounts owed totaling $31,770 to the Company’s drug product manufacturer and raw material suppliers, $24,751 to suppliers of services used in the clinical trial, $22,282 for legal services and other miscellaneous items totaling $9,711. By the first week of November 2014, the September 30, 2014 amounts included in accounts payable had been substantially paid. As of December 31, 2013, Current Liabilities included accounts payable of $76,109, which amounts were subsequently paid in 2014.